 | • レポートコード：MRC2312MG09609 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、79ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のホルモン放出アゴニスト市場規模と予測を収録しています。・世界のホルモン放出アゴニスト市場：売上、2018年-2023年、2024年-2029年 ・世界のホルモン放出アゴニスト市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のホルモン放出アゴニスト市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ホルモン療法」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ホルモン放出アゴニストのグローバル主要企業は、Johnson & Johnson、 Astellas Pharma Inc、 Ipsen Pharma、 Sanofi、 Bayer AG、 AstraZeneca、 Pfizer、 Teva Pharmaceutical Industries、 Abbott、 GlaxoSmithKlineなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ホルモン放出アゴニストのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のホルモン放出アゴニスト市場：タイプ別、2018年-2023年、2024年-2029年 世界のホルモン放出アゴニスト市場：タイプ別市場シェア、2022年 ・ホルモン療法、免疫療法、標的療法、化学療法、その他 世界のホルモン放出アゴニスト市場：用途別、2018年-2023年、2024年-2029年 世界のホルモン放出アゴニスト市場：用途別市場シェア、2022年 ・病院薬局、小売薬局、オンライン薬局 世界のホルモン放出アゴニスト市場：地域・国別、2018年-2023年、2024年-2029年 世界のホルモン放出アゴニスト市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるホルモン放出アゴニストのグローバル売上、2018年-2023年 ・主要企業におけるホルモン放出アゴニストのグローバル売上シェア、2022年 ・主要企業におけるホルモン放出アゴニストのグローバル販売量、2018年-2023年 ・主要企業におけるホルモン放出アゴニストのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Johnson & Johnson、 Astellas Pharma Inc、 Ipsen Pharma、 Sanofi、 Bayer AG、 AstraZeneca、 Pfizer、 Teva Pharmaceutical Industries、 Abbott、 GlaxoSmithKline ************************************************************* ・調査・分析レポートの概要 ホルモン放出アゴニスト市場の定義 市場セグメント 世界のホルモン放出アゴニスト市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のホルモン放出アゴニスト市場規模 世界のホルモン放出アゴニスト市場規模：2022年 VS 2029年 世界のホルモン放出アゴニスト市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのホルモン放出アゴニストの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のホルモン放出アゴニスト製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：ホルモン療法、免疫療法、標的療法、化学療法、その他 ホルモン放出アゴニストのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院薬局、小売薬局、オンライン薬局 ホルモン放出アゴニストの用途別グローバル売上・予測 ・地域別市場分析 地域別ホルモン放出アゴニスト市場規模 2022年と2029年 地域別ホルモン放出アゴニスト売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Johnson & Johnson、 Astellas Pharma Inc、 Ipsen Pharma、 Sanofi、 Bayer AG、 AstraZeneca、 Pfizer、 Teva Pharmaceutical Industries、 Abbott、 GlaxoSmithKline ... |
This research report provides a comprehensive analysis of the Hormone-Releasing Agonists market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Hormone-Releasing Agonists market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Hormone-Releasing Agonists, challenges faced by the industry, and potential opportunities for market players.
The global Hormone-Releasing Agonists market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Hormone-Releasing Agonists market presents opportunities for various stakeholders, including Hospital Pharmacies, Retail Pharmacies. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Hormone-Releasing Agonists market. Additionally, the growing consumer demand present avenues for market expansion.
The global Hormone-Releasing Agonists market was valued at US$ 133 million in 2022 and is projected to reach US$ 232.8 million by 2029, at a CAGR of 7.1% during the forecast period.
The market for hormone-releasing agonists may experience growth due to an aging population and increasing awareness of hormone-related conditions such as prostate cancer (for which hormone therapy is often used) and hormone deficiencies.
Key Features:
The research report on the Hormone-Releasing Agonists market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Hormone-Releasing Agonists market.
Market Overview: The report provides a comprehensive overview of the Hormone-Releasing Agonists market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Hormonal Therapy, Immunotherapy), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Hormone-Releasing Agonists market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Hormone-Releasing Agonists market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Hormone-Releasing Agonists market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Hormone-Releasing Agonists market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Hormone-Releasing Agonists market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Hormone-Releasing Agonists market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Hormone-Releasing Agonists, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Hormone-Releasing Agonists market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Hormone-Releasing Agonists market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Hormonal Therapy
Immunotherapy
Targeted Therapy
Chemotherapy
Others
Market segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Hormone-Releasing Agonists Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Johnson & Johnson
Astellas Pharma Inc
Ipsen Pharma
Sanofi
Bayer AG
AstraZeneca
Pfizer
Teva Pharmaceutical Industries
Abbott
GlaxoSmithKline
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hormone-Releasing Agonists, market overview.
Chapter 2: Global Hormone-Releasing Agonists market size in revenue and volume.
Chapter 3: Detailed analysis of Hormone-Releasing Agonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hormone-Releasing Agonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hormone-Releasing Agonists capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Hormone-Releasing Agonists Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hormone-Releasing Agonists Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hormone-Releasing Agonists Overall Market Size
2.1 Global Hormone-Releasing Agonists Market Size: 2022 VS 2029
2.2 Global Hormone-Releasing Agonists Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Hormone-Releasing Agonists Sales: 2018-2029
3 Company Landscape
3.1 Top Hormone-Releasing Agonists Players in Global Market
3.2 Top Global Hormone-Releasing Agonists Companies Ranked by Revenue
3.3 Global Hormone-Releasing Agonists Revenue by Companies
3.4 Global Hormone-Releasing Agonists Sales by Companies
3.5 Global Hormone-Releasing Agonists Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hormone-Releasing Agonists Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hormone-Releasing Agonists Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hormone-Releasing Agonists Players in Global Market
3.8.1 List of Global Tier 1 Hormone-Releasing Agonists Companies
3.8.2 List of Global Tier 2 and Tier 3 Hormone-Releasing Agonists Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Hormone-Releasing Agonists Market Size Markets, 2022 & 2029
4.1.2 Hormonal Therapy
4.1.3 Immunotherapy
4.1.4 Targeted Therapy
4.1.5 Chemotherapy
4.1.6 Others
4.2 By Type – Global Hormone-Releasing Agonists Revenue & Forecasts
4.2.1 By Type – Global Hormone-Releasing Agonists Revenue, 2018-2023
4.2.2 By Type – Global Hormone-Releasing Agonists Revenue, 2024-2029
4.2.3 By Type – Global Hormone-Releasing Agonists Revenue Market Share, 2018-2029
4.3 By Type – Global Hormone-Releasing Agonists Sales & Forecasts
4.3.1 By Type – Global Hormone-Releasing Agonists Sales, 2018-2023
4.3.2 By Type – Global Hormone-Releasing Agonists Sales, 2024-2029
4.3.3 By Type – Global Hormone-Releasing Agonists Sales Market Share, 2018-2029
4.4 By Type – Global Hormone-Releasing Agonists Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Hormone-Releasing Agonists Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application – Global Hormone-Releasing Agonists Revenue & Forecasts
5.2.1 By Application – Global Hormone-Releasing Agonists Revenue, 2018-2023
5.2.2 By Application – Global Hormone-Releasing Agonists Revenue, 2024-2029
5.2.3 By Application – Global Hormone-Releasing Agonists Revenue Market Share, 2018-2029
5.3 By Application – Global Hormone-Releasing Agonists Sales & Forecasts
5.3.1 By Application – Global Hormone-Releasing Agonists Sales, 2018-2023
5.3.2 By Application – Global Hormone-Releasing Agonists Sales, 2024-2029
5.3.3 By Application – Global Hormone-Releasing Agonists Sales Market Share, 2018-2029
5.4 By Application – Global Hormone-Releasing Agonists Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Hormone-Releasing Agonists Market Size, 2022 & 2029
6.2 By Region – Global Hormone-Releasing Agonists Revenue & Forecasts
6.2.1 By Region – Global Hormone-Releasing Agonists Revenue, 2018-2023
6.2.2 By Region – Global Hormone-Releasing Agonists Revenue, 2024-2029
6.2.3 By Region – Global Hormone-Releasing Agonists Revenue Market Share, 2018-2029
6.3 By Region – Global Hormone-Releasing Agonists Sales & Forecasts
6.3.1 By Region – Global Hormone-Releasing Agonists Sales, 2018-2023
6.3.2 By Region – Global Hormone-Releasing Agonists Sales, 2024-2029
6.3.3 By Region – Global Hormone-Releasing Agonists Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Hormone-Releasing Agonists Revenue, 2018-2029
6.4.2 By Country – North America Hormone-Releasing Agonists Sales, 2018-2029
6.4.3 US Hormone-Releasing Agonists Market Size, 2018-2029
6.4.4 Canada Hormone-Releasing Agonists Market Size, 2018-2029
6.4.5 Mexico Hormone-Releasing Agonists Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Hormone-Releasing Agonists Revenue, 2018-2029
6.5.2 By Country – Europe Hormone-Releasing Agonists Sales, 2018-2029
6.5.3 Germany Hormone-Releasing Agonists Market Size, 2018-2029
6.5.4 France Hormone-Releasing Agonists Market Size, 2018-2029
6.5.5 U.K. Hormone-Releasing Agonists Market Size, 2018-2029
6.5.6 Italy Hormone-Releasing Agonists Market Size, 2018-2029
6.5.7 Russia Hormone-Releasing Agonists Market Size, 2018-2029
6.5.8 Nordic Countries Hormone-Releasing Agonists Market Size, 2018-2029
6.5.9 Benelux Hormone-Releasing Agonists Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Hormone-Releasing Agonists Revenue, 2018-2029
6.6.2 By Region – Asia Hormone-Releasing Agonists Sales, 2018-2029
6.6.3 China Hormone-Releasing Agonists Market Size, 2018-2029
6.6.4 Japan Hormone-Releasing Agonists Market Size, 2018-2029
6.6.5 South Korea Hormone-Releasing Agonists Market Size, 2018-2029
6.6.6 Southeast Asia Hormone-Releasing Agonists Market Size, 2018-2029
6.6.7 India Hormone-Releasing Agonists Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Hormone-Releasing Agonists Revenue, 2018-2029
6.7.2 By Country – South America Hormone-Releasing Agonists Sales, 2018-2029
6.7.3 Brazil Hormone-Releasing Agonists Market Size, 2018-2029
6.7.4 Argentina Hormone-Releasing Agonists Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Hormone-Releasing Agonists Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Hormone-Releasing Agonists Sales, 2018-2029
6.8.3 Turkey Hormone-Releasing Agonists Market Size, 2018-2029
6.8.4 Israel Hormone-Releasing Agonists Market Size, 2018-2029
6.8.5 Saudi Arabia Hormone-Releasing Agonists Market Size, 2018-2029
6.8.6 UAE Hormone-Releasing Agonists Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Hormone-Releasing Agonists Major Product Offerings
7.1.4 Johnson & Johnson Hormone-Releasing Agonists Sales and Revenue in Global (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Astellas Pharma Inc
7.2.1 Astellas Pharma Inc Company Summary
7.2.2 Astellas Pharma Inc Business Overview
7.2.3 Astellas Pharma Inc Hormone-Releasing Agonists Major Product Offerings
7.2.4 Astellas Pharma Inc Hormone-Releasing Agonists Sales and Revenue in Global (2018-2023)
7.2.5 Astellas Pharma Inc Key News & Latest Developments
7.3 Ipsen Pharma
7.3.1 Ipsen Pharma Company Summary
7.3.2 Ipsen Pharma Business Overview
7.3.3 Ipsen Pharma Hormone-Releasing Agonists Major Product Offerings
7.3.4 Ipsen Pharma Hormone-Releasing Agonists Sales and Revenue in Global (2018-2023)
7.3.5 Ipsen Pharma Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Hormone-Releasing Agonists Major Product Offerings
7.4.4 Sanofi Hormone-Releasing Agonists Sales and Revenue in Global (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 Bayer AG
7.5.1 Bayer AG Company Summary
7.5.2 Bayer AG Business Overview
7.5.3 Bayer AG Hormone-Releasing Agonists Major Product Offerings
7.5.4 Bayer AG Hormone-Releasing Agonists Sales and Revenue in Global (2018-2023)
7.5.5 Bayer AG Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Hormone-Releasing Agonists Major Product Offerings
7.6.4 AstraZeneca Hormone-Releasing Agonists Sales and Revenue in Global (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Hormone-Releasing Agonists Major Product Offerings
7.7.4 Pfizer Hormone-Releasing Agonists Sales and Revenue in Global (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 Teva Pharmaceutical Industries
7.8.1 Teva Pharmaceutical Industries Company Summary
7.8.2 Teva Pharmaceutical Industries Business Overview
7.8.3 Teva Pharmaceutical Industries Hormone-Releasing Agonists Major Product Offerings
7.8.4 Teva Pharmaceutical Industries Hormone-Releasing Agonists Sales and Revenue in Global (2018-2023)
7.8.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.9 Abbott
7.9.1 Abbott Company Summary
7.9.2 Abbott Business Overview
7.9.3 Abbott Hormone-Releasing Agonists Major Product Offerings
7.9.4 Abbott Hormone-Releasing Agonists Sales and Revenue in Global (2018-2023)
7.9.5 Abbott Key News & Latest Developments
7.10 GlaxoSmithKline
7.10.1 GlaxoSmithKline Company Summary
7.10.2 GlaxoSmithKline Business Overview
7.10.3 GlaxoSmithKline Hormone-Releasing Agonists Major Product Offerings
7.10.4 GlaxoSmithKline Hormone-Releasing Agonists Sales and Revenue in Global (2018-2023)
7.10.5 GlaxoSmithKline Key News & Latest Developments
8 Global Hormone-Releasing Agonists Production Capacity, Analysis
8.1 Global Hormone-Releasing Agonists Production Capacity, 2018-2029
8.2 Hormone-Releasing Agonists Production Capacity of Key Manufacturers in Global Market
8.3 Global Hormone-Releasing Agonists Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hormone-Releasing Agonists Supply Chain Analysis
10.1 Hormone-Releasing Agonists Industry Value Chain
10.2 Hormone-Releasing Agonists Upstream Market
10.3 Hormone-Releasing Agonists Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hormone-Releasing Agonists Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer